Building on recent efforts to streamline premarket review of medical devices, on April 12, 2018, the Food and Drug Administration (FDA) issued a draft guidance seeking to expand use of the historically underutilized Abbreviated 510(k) submission program, through which device sponsors may rely on guidance documents, special controls, and FDA-recognized consensus standards to demonstrate substantial equivalence.
Please see full publication below for more information.